Search: onr:"swepub:oai:DiVA.org:umu-90857" > Four-Group Classifi...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03747naa a2200409 4500 | |
001 | oai:DiVA.org:umu-90857 | |
003 | SwePub | |
008 | 140701s2014 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-908572 URI |
024 | 7 | a https://doi.org/10.1161/CIRCIMAGING.113.0012752 DOI |
040 | a (SwePub)umu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Bang, Casper N.4 aut |
245 | 1 0 | a Four-Group Classification of Left Ventricular Hypertrophy Based on Ventricular Concentricity and Dilatation Identifies a Low-Risk Subset of Eccentric Hypertrophy in Hypertensive Patients |
264 | 1 | c 2014 |
338 | a print2 rdacarrier | |
520 | a Background-Left ventricular hypertrophy (LVH; high LV mass [LVM]) is traditionally classified as concentric or eccentric based on LV relative wall thickness. We evaluated the prediction of subsequent adverse events in a new 4-group LVH classification based on LV dilatation (high LV end-diastolic volume [EDV] index) and concentricity (mass/end-diastolic volume [M/EDV](2/3)) in hypertensive patients. Methods and Results-In the Losartan Intervention for Endpoint Reduction (LIFE) echocardiography substudy, 939 hypertensive patients with measurable LVM at baseline were randomized to a mean of 4.8 years of losartan- or atenolol-based treatment. Patients with LVH (LVM/body surface area >= 116 and >= 96 g/m(2) in men and woman, respectively) were divided into 4 groups-concentric nondilated (increased M/EDV, normal EDV), eccentric dilated (increased EDV, normal M/EDV), concentric dilated (increased M/EDV and EDV), and eccentric nondilated (normal M/EDV and EDV)-and compared with patients with normal LVM. Time-varying LVH classes were tested for association with all-cause and cardiovascular mortality and a composite end point of myocardial infarction, stroke, heart failure, and cardiovascular death in multivariable Cox analyses. At baseline, the LVs were categorized as eccentric nondilated in 12%, eccentric dilated in 20%, concentric nondilated in 29%, concentric dilated in 14%, and normal LVM in 25%. Treatment changed the prevalence of 4 LVH groups to 23%, 4%, 5%, and 7%; 62% had normal LVM after 4 years. In time-varying Cox analyses, compared with normal LVM, those with eccentric dilated and both concentric nondilated and dilated LVH had increased risks of all-cause or cardiovascular mortality or the composite end point, whereas the eccentric nondilated group did not. Conclusions-Hypertensive patients with relatively mild LVH without either increased LV volume or concentricity have similar risk of all-cause mortality or cardiovascular events because hypertensive patients with normal LVM seem to be a low-risk group. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng |
653 | a hypertension | |
653 | a hypertrophy | |
653 | a left ventricular geometry | |
700 | 1 | a Gerdts, Eva4 aut |
700 | 1 | a Aurigemma, Gerard P.4 aut |
700 | 1 | a Boman, Kurtu Umeå universitet,Medicin4 aut0 (Swepub:umu)kubo0001 |
700 | 1 | a de Simone, Giovanni4 aut |
700 | 1 | a Dahlof, Bjorn4 aut |
700 | 1 | a Kober, Lars4 aut |
700 | 1 | a Wachtell, Kristian4 aut |
700 | 1 | a Devereux, Richard B.4 aut |
710 | 2 | a Umeå universitetb Medicin4 org |
773 | 0 | t Circulation Cardiovascular Imagingg 7:3, s. 422-429q 7:3<422-429x 1941-9651x 1942-0080 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-90857 |
856 | 4 8 | u https://doi.org/10.1161/CIRCIMAGING.113.001275 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Copy and save the link in order to return to this view